Vashisht D, Sengupta P, Bansal N. Lupus pernio. Med J Armed Forces India. 2014;70(3):281–3. https://doi.org/10.1016/j.mjafi.2012.05.004.

Polverino F, Balestro E, Spagnolo P. clinical presentations, pathogenesis, and therapy of sarcoidosis: State of the art. J Clin Med, 2020;9.

Birnie DH, Nery PB, Ha AC, Beanlands RSB. Cardiac Sarcoidosis. J Am Coll Cardiol. 2016;68:411–21.

Article  PubMed  Google Scholar 

Lynch JP 3rd, Hwang J, Bradfield J, Fishbein M, Shivkumar K, Tung R. Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment. Semin Respir Crit Care Med. 2014;35:372–90.

Article  PubMed  PubMed Central  Google Scholar 

Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305–23.

Article  PubMed  Google Scholar 

Terasaki F, Azuma A, Anzai T, et al. JCS 2016 Guideline on diagnosis and treatment of cardiac sarcoidosis - digest version -. Circ J. 2019;83:2329–88.

Article  PubMed  Google Scholar 

Judson MA, Costabel U, Drent M, et al. The WASOG sarcoidosis organ assessment instrument: An update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis : official journal of WASOG. 2014;31:19–27.

Google Scholar 

Uemura A, Morimoto S, Hiramitsu S, Kato Y, Ito T, Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J. 1999;138:299–302.

Article  CAS  PubMed  Google Scholar 

Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation. 2007;116:2216–33.

Article  PubMed  Google Scholar 

Salerno M, Sharif B, Arheden H et al. Recent advances in cardiovascular magnetic resonance: techniques and applications. Circ Cardiovasc Imaging. 2017;10.

Salerno M, Sharif B, Arheden H, et al. Recent advances in cardiovascular magnetic. Resonance. 2017;10:e003951.

Google Scholar 

Okasha O, Kazmirczak F, Chen KHA, Farzaneh‐Far A, Shenoy C. Myocardial involvement in patients with histologically diagnosed cardiac sarcoidosis: A systematic review and meta‐analysis of gross pathological images from autopsy or cardiac transplantation cases. 2019;8:e011253.

Blankstein R, Waller AH. Evaluation of known or suspected cardiac sarcoidosis. Circ Cardiovasc Imaging. 2016;9:e000867.

Article  PubMed  Google Scholar 

Patel MR, Cawley PJ, Heitner JF et al. Detection of myocardial damage in patients with sarcoidosis. 2009;120:1969-1977.

Wand AL, Chrispin J, Saad E, Mukherjee M, Hays AG, Gilotra NA. Current state and future directions of multimodality imaging in cardiac sarcoidosis. Front Cardiovasc Med. 2021;8:785279.

Article  CAS  PubMed  Google Scholar 

Cheung E, Ahmad S, Aitken M, et al. Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis. Eur J Hybrid Imaging. 2021;5:24.

Article  PubMed  PubMed Central  Google Scholar 

Mathai SV, Patel S, Jorde UP, Rochlani Y. Epidemiology, pathogenesis, and diagnosis of cardiac sarcoidosis. Methodist Debakey Cardiovasc J. 2022;18:78–93.

Article  PubMed  PubMed Central  Google Scholar 

Vignaux O. Cardiac sarcoidosis: Spectrum of MRI features. 2005;184:249-254.

Athwal PSS, Chhikara S, Ismail MF, et al. Cardiovascular magnetic resonance imaging phenotypes and long-term outcomes in patients with suspected cardiac sarcoidosis. JAMA Cardiol. 2022;7:1057–66.

Article  PubMed  PubMed Central  Google Scholar 

Greulich S, Kitterer D, Latus J et al. Comprehensive cardiovascular magnetic resonance assessment in patients with sarcoidosis and preserved left ventricular ejection fraction. Circ Cardiovasc Imaging. 2016;9.

Aitken M, Davidson M, Chan MV, et al. Prognostic value of cardiac MRI and FDG PET in cardiac sarcoidosis: A systematic review and meta-analysis. Radiology. 2023;307:e222483.

Article  PubMed  Google Scholar 

Velangi PS, Chen KA, Kazmirczak F, et al. Right ventricular abnormalities on cardiovascular magnetic resonance imaging in patients with sarcoidosis. JACC Cardiovasc Imaging. 2020;13:1395–405.

Article  PubMed  PubMed Central  Google Scholar 

Murtagh G, Laffin LJ, Beshai JF, et al. Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: Risk stratification using cardiovascular magnetic resonance. Circ Cardiovasc Imaging. 2016;9:e003738.

Article  PubMed  PubMed Central  Google Scholar 

Kumar S, Barbhaiya C, Nagashima K, et al. Ventricular tachycardia in cardiac. Sarcoidosis. 2015;8:87–93.

Google Scholar 

Birnie DHMD, Sauer WHMDFC, Bogun FMD, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1304–23.

Article  Google Scholar 

Chareonthaitawee P, Beanlands RS, Chen W, et al. Joint SNMMI–ASNC expert consensus document on the role of ¹⁸F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Med. 2017;58:1341–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Divakaran S, Osborne MT. Preparation is everything: The impact of a structured preparation protocol on cardiac (18)F-FDG PET imaging for cardiac sarcoidosis. J Nuclear Cardiol : official publication of the American Society of Nuclear Cardiology. 2021;28:2638–41.

Article  Google Scholar 

Kherajani P, Farag AA, Morgan WS, Hage FG, Bhambhvani P. Complete resolution of focal-on-diffuse myocardial activity pattern on FDG PET-CT by prolonging the dietary preparation protocol in cardiac sarcoidosis. J Nuclear Cardiol : official publication of the American Society of Nuclear Cardiology. 2023;30:2525–30.

Article  Google Scholar 

Ahmadian A, Brogan A, Berman J, et al. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J Nucl Cardiol. 2014;21:925–39.

Article  PubMed  Google Scholar 

Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1304–23.

Article  Google Scholar 

Kim S-J, Pak K, Kim K. Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis. J Nucl Cardiol. 2020;27:2103–15.

Article  PubMed  Google Scholar 

Youssef G, Leung E, Mylonas I, et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nuclear Med : official publication, Society of Nuclear Medicine. 2012;53:241–8.

Article  CAS  Google Scholar 

Blankstein R, Osborne M, Naya M, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014;63:329–36.

Article  PubMed  Google Scholar 

Dilsizian V, Bacharach SL, Beanlands RS, et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol. 2016;23:1187–226.

Article  PubMed  Google Scholar 

Nakata T, Nakajima K, Naya M, et al. Multicenter registry in the Japanese cardiac sarcoidosis prognostic (J-CASP) study: Baseline characteristics and validation of the non-invasive approach using (18)F-FDG PET. Ann Nucl Cardiol. 2022;8:42–50.

Article  PubMed  PubMed Central  Google Scholar 

Ahmadian A, Pawar S, Govender P, Berman J, Ruberg FL, Miller EJ. The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis. J Nucl Cardiol. 2017;24:413–24.

Article  PubMed  Google Scholar 

Muser D, Santangeli P, Castro SA, et al. Prognostic role of serial quantitative evaluation of (18)F-fluorodeoxyglucose uptake by PET/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia. Eur J Nucl Med Mol Imaging. 2018;45:1394–404.

Article  CAS  PubMed  Google Scholar 

Al Hayja MA, Vinjamuri S. Cardiac sarcoidosis: the role of cardiac MRI and (18)F-FDG-PET/CT in the diagnosis and treatment follow-up. Br J Cardiol. 2023;30:7.

PubMed  PubMed Central  Google Scholar 

Aitken M, Davidson M, Chan MV, et al. Prognostic value of cardiac MRI and FDG PET in cardiac sarcoidosis: A systematic review and meta-analysis. Radiology. 2023;307:e222483.

Article  PubMed  Google Scholar 

Gowani Z, Habibi M, Okada DR, et al. Utility of cardiac magnetic resonance imaging versus cardiac positron emission tomography for risk stratification for ventricular arrhythmias in patients with cardiac sarcoidosis. Am J Cardiol. 2020;134:123–9.

Article  PubMed  Google Scholar 

Okune M, Yasuda M, Soejima N, et al. Diagnostic utility of fusion 18F-fluorodeoxyglucose positron emission tomography/cardiac magnetic resonance imaging in cardiac sarcoidosis. J Nucl Cardiol. 2022;29:753–64.